---
$id: https://graph.org.ai/products/commodity/51131722
$type: Product
source: UNSPSC
code: "51131722"
title: "Carafiban"
class: "51131700"
classTitle: "Thrombolytic drugs and platelet aggregation inhibitors"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Carafiban

**UNSPSC Code**: 51131722
**Class**: [Thrombolytic drugs and platelet aggregation inhibitors](Thrombolytic drugs and platelet aggregation inhibitors.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a thrombolytic agent with the molecular formula C24H27N5O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 39IWK4M2UW, chemically known as ethyl (s)-beta-(2-((s)-4-(p-amidinophenyl)-4-methyl-2,5-dioxo-1-imidazolidinyl)acetamido)hydrocinnamate. but generally known as carafiban, which bears US NIH Compound Identifier 193944. European Medicines Agency schedules Carafiban in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06084MIG. The term CARAFIBAN is an International Non-Proprietary Name. Most nations schedule carafiban under HS 29332990 and SITC 51573. As of Q4 2014, CARAFIBAN remains the US FDA Preferred Term for this commodity. Carafiban bears US NLM identifiers UMLS ID C2698985 and NCI Concept Code C76113. SMILES: O=C1N(C(=O)NC1(C1CCC(CC1)C(=N)N)C)CC(=O)NC(CC(=O)OCC)C1CCCCC1.

